Pilot Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Feasibility of an Intranasal Oxytocin in Improving Social Cognition in Individuals Living with Alzheimer’s Disease

BACKGROUND: Individuals living with Alzheimer’s disease (AD) demonstrate extensive deficits in social cognition. To date, no studies have investigated the feasibility of an intranasal oxytocin (INOT) treatment to improve social cognition in individuals living with AD. OBJECTIVE: We conducted a pilot...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaelian, Johannes C., McCade, Donna, Hoyos, Camilla M., Brodaty, Henry, Harrison, Fleur, Henry, Julie D., Guastella, Adam J., Naismith, Sharon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357119/
https://www.ncbi.nlm.nih.gov/pubmed/37483320
http://dx.doi.org/10.3233/ADR-230013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357119/
https://www.ncbi.nlm.nih.gov/pubmed/37483320
http://dx.doi.org/10.3233/ADR-230013

Ejemplares similares